Search for: "Roche v. Roche"
Results 721 - 740
of 925
Sorted by Relevance
|
Sort by Date
27 Nov 2012, 8:43 am
And now, here is a legal first, straight from the pen (well, keyboard) of our Mr Justice Arnold in joined cases Actavis Group hf v Eli Lilly & Company (USA)/Medis ehf v Eli Lilly & Company (USA) [2012] EWHC 3316 (Pat) on whether the English Courts have jurisdiction over issues of infringement of foreign-designated patents. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
31 Jul 2010, 4:25 am
Hoffmann-La Roche, Ltd., 580 F.3d 1340, 1374 (Fed. [read post]
21 Feb 2014, 8:53 am
Ramirez v. [read post]
13 Aug 2009, 12:10 pm
"); Hoffman-La Roche Inc. v. [read post]
17 Aug 2009, 12:26 am
"); Hoffman-La Roche Inc. v. [read post]
31 May 2011, 12:19 am
May 25, 2011 Maria Roche Must lawyers blog and tweet? [read post]
24 Feb 2016, 10:04 am
Hoffmann-La Roche Ltd. v. [read post]
12 Mar 2012, 1:47 pm
The ‘Junk’ decision in 2005 (C-188/03, Junk v Kuhnel) has meant, that worker consultations need now take place before any final decision on job losses is taken. [read post]
1 Feb 2016, 10:43 am
Hoffman-La Roche Ltd., 580 F.3d 1340,1369 (Fed. [read post]
11 Feb 2015, 12:23 pm
Bayer’s predecessor, Hoffmann-La Roche, filed a US application for FLANAX in February 2004. [read post]
3 Mar 2010, 5:05 am
(Patent Docs) US: Court report – Numerous false marking suits filed by Simonian against various respondents concerning products including: Claritin-D, Hypo Tears, Interceptor, Prevacid, Advil, Heartguard Heartworm Canine Medication (Patent Docs) US: False marking suit brought over marking of Accu-Chek products: O’Neill v Roche Diagnostics Corp (Patent Docs) US: President’s health care plan includes pay-for-delay ban and biosimilar regulatory pathway (Patent Docs)… [read post]
3 Mar 2010, 5:05 am
(Patent Docs) US: Court report – Numerous false marking suits filed by Simonian against various respondents concerning products including: Claritin-D, Hypo Tears, Interceptor, Prevacid, Advil, Heartguard Heartworm Canine Medication (Patent Docs) US: False marking suit brought over marking of Accu-Chek products: O’Neill v Roche Diagnostics Corp (Patent Docs) US: President’s health care plan includes pay-for-delay ban and biosimilar regulatory pathway (Patent Docs)… [read post]
7 Apr 2010, 4:30 am
– Myriad stock prices: Association of Molecular Pathology v USPTO (Innovationpartners) US: Federal judge in Myriad patent case says invalidation of gene patents does not violate TRIPS: Association of Molecular Pathology v USPTO (KEI) US: ACLU gene patent decision from an investor’s perspective: A black eye for the US patent system: Association of Molecular Pathology v USPTO (Holman's Biotech IP Blog) US: Association of Molecular Pathology v USPTO:… [read post]
4 May 2020, 4:26 pm
In its 2012 decision, Mayo Collaborative Servs. v. [read post]
28 Jun 2010, 3:25 pm
Roche Molecular Systems (09-1159). [read post]
26 Dec 2007, 8:05 am
Hoffman-La Roche, Inc., 170 P.3d 254 (Ariz. [read post]
12 Sep 2021, 3:10 am
On this third point, Mr Justice Birss (as he then was) provided an explanation as to the German injunction gap and the interaction with UK patent proceedings at [14]-[19] of his decision, summarizing previous decisions (HTC v Apple, ZTE, v Ericsson, Garmin v Phillips) where Mr Justice Arnold (as he then was) consistently expressed the view that the presence of a possible German injunction gap "was a factor to take into account". [read post]
7 Oct 2015, 3:28 am
U.S. v. [read post]
6 May 2016, 12:30 pm
Hoffman-La Roche, Inc., 2007 WL 4042757, at *3 (N.D. [read post]
